id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0579-0002,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing; Forms FDA 3486 and 3486A",Notice,30 Day Proposed Information Collection,2013-12-04T05:00:00Z,2013,12,2013-12-04T05:00:00Z,2014-01-04T04:59:59Z,2013-12-30T02:01:45Z,2013-28990,0,0,09000064814a61ed
FDA-2013-N-0579-0001,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing; Forms FDA 3486 and 3486A",Notice,General Notice,2013-06-05T04:00:00Z,2013,6,2013-06-05T04:00:00Z,2013-08-06T03:59:59Z,2013-06-05T14:27:01Z,2013-13279,0,0,090000648130b88c